Generate Biomedicines Inc. Common Stock (GENB)
Stock · NASDAQ · Health Care
$15.33as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$12.54
Industry
Biotechnology: Pharmaceutical Preparations
About GENB
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 312
- Website
- generatebiomedicines.com
Fundamentals
- 1-day range
- $14.74$16.3
- Market cap
- $1.78B
- P/E (trailing)
- —
- P/E (forward)
- -6.72
- EPS (trailing)
- $-2.10
- Dividend yield
- —
- Beta
- 0.49
- Avg. volume
- 997.5K
52-week range
$11$22.67
Next earnings: November 5, 2026 · EPS estimate $-0.55
Forecasts
5 analyst ratings
Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$30
+95.7%
Median
$26
+69.6%
Low
$22
+43.5%
Generate Biomedicines Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GENBGenerate Biomedicines Inc. Common Stock$15.33▼ 2.79%Market cap $1.78BP/E —$11$22.67
- SRPTSarepta Therapeutics Inc. Common Stock (DE)$20.85▼ 3.43%Market cap $1.77BP/E —
- SNDXSyndax Pharmaceuticals Inc. Common Stock$19.55▼ 3.05%Market cap $1.76BP/E —$12.99$25.59
- BCAXBicara Therapeutics Inc. Common Stock$23.42▼ 5.70%Market cap $1.81BP/E —$10.3$30.99
- CMPSCOMPASS Pathways Plc American Depository Shares$13.71▼ 6.35%Market cap $1.83BP/E —
- NBTXNanobiotix S.A. American Depositary Shares$41.28▼ 8.59%Market cap $1.83BP/E —$7.02$47.66
- LKFTLakefront Biotherapeutics American Depositary Shares$28.86▼ 1.97%Market cap $1.72BP/E 3.29$22.32$27.12
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GENB Generate Biomedicines Inc. Common Stock | $1.78B | — | $15.33 | ▼ 2.79% | $11$22.67 |
| SRPT Sarepta Therapeutics Inc. Common Stock (DE) | $1.77B | — | $20.85 | ▼ 3.43% | |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | $1.76B | — | $19.55 | ▼ 3.05% | $12.99$25.59 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.81B | — | $23.42 | ▼ 5.70% | $10.3$30.99 |
| CMPS COMPASS Pathways Plc American Depository Shares | $1.83B | — | $13.71 | ▼ 6.35% | |
| NBTX Nanobiotix S.A. American Depositary Shares | $1.83B | — | $41.28 | ▼ 8.59% | $7.02$47.66 |
| LKFT Lakefront Biotherapeutics American Depositary Shares | $1.72B | 3.29 | $28.86 | ▼ 1.97% | $22.32$27.12 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Ulta Beauty To Rally Around 20%? Here Are 10 Top Analyst Forecasts For FridayBenzinga · 8/28/2026
- HC Wainwright & Co. Maintains Buy on Generate Biomedicines, Raises Price Target to $30Benzinga · 8/28/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 8/26/2026
- Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech NewsSeekingAlpha · 8/10/2026
- Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business UpdateYahoo · 8/6/2026
- Generate Biomedicines Q2 EPS $(0.52) Beats $(0.57) Estimate, Sales $6.314M Miss $6.625M EstimateBenzinga · 8/6/2026
- This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of ItYahoo · 8/5/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 89.87M
- Total value held
- $1.10B
- Institutional holders
- 55
Top holders this quarter
- Unknown62.67M
- Unknown4.22M
- Unknown4.00M
- Unknown3.59M
- Unknown2.11M
- Unknown1.94M
- Unknown1.72M
- Unknown1.42M
- Unknown1.11M
- Unknown833.3K
See the full, filterable feed with live charts on the MarketWall dashboard.